---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-036837"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-04-21T23:59:59+00:00"
generated_at: "2026-05-23T10:06:04.316319+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences provides $400k loan to Vyome, extends merger deadline to June 30

## Summary
- ReShape loans Vyome up to $400k in three tranches at 8% interest, due Sept 30, 2025.
- Merger termination date extended from March 31 to June 30, 2025.
- Termination fee reduced to $1M minus outstanding note amounts if ReShape terminates.
- Note becomes senior secured if merger fails due to concurrent financing default.

## SEC filing metadata
- accession: 0001104659-25-036837
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-04-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925036837/0001104659-25-036837-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925036837/tm2512794d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-036837
- JSON: https://secwatch.observer/filing/0001104659-25-036837.json
- Plain text: https://secwatch.observer/filing/0001104659-25-036837.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.